Cargando…

The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease

Helicobacter pylori (H. pylori) which colonizes the stomach can cause a wide array of gastric disorders, including chronic gastritis, peptic ulcer, and gastric cancer. Recently, accumulating evidence has implicated H. pylori infection in extragastrointestinal diseases such as cardiovascular diseases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Dan-dan, He, Cong, Ai, Hong-hui, Huang, Ying, Lu, Nong-hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423951/ https://www.ncbi.nlm.nih.gov/pubmed/28539915 http://dx.doi.org/10.3389/fmicb.2017.00743

Ejemplares similares

Adhesion and Invasion of Gastric Mucosa Epithelial Cells by Helicobacter pylori
por: Huang, Ying, et al.
Publicado: (2016)

Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China
por: Fan, Nengguang, et al.
Publicado: (2018)

Non-pylori Helicobacters (NHPHs) Induce Shifts in Gastric Microbiota in Helicobacter pylori-Infected Patients
por: Peng, Xianhui, et al.
Publicado: (2017)

Integrative Analysis of Differential lncRNA/mRNA Expression Profiling in Helicobacter pylori Infection-Associated Gastric Carcinogenesis
por: Li, Nianshuang, et al.
Publicado: (2020)

Transforming growth factor-β: an important mediator in Helicobacter pylori-associated pathogenesis
por: Li, Nianshuang, et al.
Publicado: (2015)

Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance
por: Hu, Yi, et al.
Publicado: (2017)

Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication
por: Hu, Yi, et al.
Publicado: (2022)

Multidrug resistance in Helicobacter pylori infection
por: Dascălu, Raluca Ioana, et al.
Publicado: (2023)

Relevance between Helicobacter pylori Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran
por: Mohammadifard, Mahyar, et al.
Publicado: (2019)

Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China
por: Wang, Weijun, et al.
Publicado: (2022)

Bacteriophages of Helicobacter pylori
por: Muñoz, Angela B., et al.
Publicado: (2020)

Treatment of refractory Helicobacter pylori infection: A new challenge for clinicians
por: Xu, XinBo, et al.
Publicado: (2022)

The management of Helicobacter pylori infection and prevention and control of gastric cancer in China
por: Hu, Yi, et al.
Publicado: (2022)

Unraveling the Novel Effect of Patchouli Alcohol Against the Antibiotic Resistance of Helicobacter pylori
por: Zhong, Yuanzun, et al.
Publicado: (2021)

Application of biomaterials in the eradication of Helicobacter pylori: A bibliometric analysis and overview
por: Shu, Chunxi, et al.
Publicado: (2023)

Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness
por: Choi, Ji Min, et al.
Publicado: (2022)

Association Between Helicobacter Pylori Infection and Non-alcoholic Fatty Liver Disease, Hepatic Adipose Deposition and Stiffness in Southwest China
por: Liu, Ying, et al.
Publicado: (2021)

No evidence for a causal link between Helicobacter pylori infection and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study
por: Liu, Yuwei, et al.
Publicado: (2022)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
por: Du, Fan, et al.
Publicado: (2021)

Metalloregulation of Helicobacter pylori physiology and pathogenesis
por: Haley, Kathryn P., et al.
Publicado: (2015)

Characteristics of different types of Helicobacter pylori: New evidence from non-amplified white light endoscopy
por: Liu, Weidong, et al.
Publicado: (2023)

Helicobacter pylori and unignorable extragastric diseases: Mechanism and implications
por: He, Junjian, et al.
Publicado: (2022)

A positive feedback loop of the TAZ/β-catenin axis promotes Helicobacter pylori-associated gastric carcinogenesis
por: Xu, Xinbo, et al.
Publicado: (2022)

A review on the research progress on non-pharmacological therapy of Helicobacter pylori
por: Luo, Qian, et al.
Publicado: (2023)

Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan
por: Okushin, Kazuya, et al.
Publicado: (2015)

Outer Membrane Vesicles of Helicobacter pylori 7.13 as Adjuvants Promote Protective Efficacy Against Helicobacter pylori Infection
por: Song, Zifan, et al.
Publicado: (2020)

The Effects of Helicobacter pylori Infection on Gastric Microbiota in Children With Duodenal Ulcer
por: Zheng, Wei, et al.
Publicado: (2022)

Recent research progress on the correlation between metabolic syndrome and Helicobacter pylori infection
por: Xie, Qinli, et al.
Publicado: (2023)

Recent progress in Helicobacter pylori treatment
por: Hu, Yi, et al.
Publicado: (2020)

Association between Helicobacter pylori infection and non-alcoholic fatty liver disease in North Chinese: a cross-sectional study
por: Jiang, Tian, et al.
Publicado: (2019)

Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque
por: Yu, Lo-Yip, et al.
Publicado: (2019)

Is Helicobacter pylori infection associated with non-alcoholic fatty liver disease in individuals undergoing bariatric surgery? Cross-sectional study
por: Valadares, Erick Coelho, et al.
Publicado: (2023)

Riboregulation in the Major Gastric Pathogen Helicobacter pylori
por: Tejada-Arranz, Alejandro, et al.
Publicado: (2021)

Effect of Temperature on Metronidazole Resistance in Helicobacter pylori
por: Gong, Meiliang, et al.
Publicado: (2021)

Insights Into the Helical Shape Complex of Helicobacter pylori
por: Holtrup, Sven, et al.
Publicado: (2022)

Gastric microbiota dysbiosis and Helicobacter pylori infection
por: Zhang, Ling, et al.
Publicado: (2023)

Therapeutic effect of demethylated hydroxylated phillygenin derivative on Helicobacter pylori infection
por: Li, Ru-Jia, et al.
Publicado: (2023)

Focusing on Helicobacter pylori infection in the elderly
por: Gong, Hang, et al.
Publicado: (2023)

Statin Decreases Helicobacter pylori Burden in Macrophages by Promoting Autophagy
por: Liao, Wei-Chih, et al.
Publicado: (2017)

Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3j53nc181d556dvjbd2menvqoi